Commerce Impacts Access to ‘Artificial Pancreas’ for US Patients

Share this post

One insulin-pump manufacturer exits North American market as the maker of the so-called "artificial pancreas" struggles to meet demand while battling an insurer for coverage of its newest technology
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply